Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies

Objective. Patients with anti-Jo-1 antibodies (Abs) and anti–melanoma differentiation-associated protein 5 (MDA5) Abs are at a higher risk of interstitial lung disease (ILD) and have a mortality rate higher than that of patients with anti-Jo-1 Abs. This study investigated differences in the clinical...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao-Han Liu, Chew-Teng Kor, Ming-Hui Hung, Kai-Hung Hsiao, Yen-Huang Cheng, Ya-Chih Tien
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2023/2988422
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items